Just six months ago, shares of Canadian cannabis company Tilray (NASDAQ:TLRY) were flying high, and trading for more than $214. Six months later, Tilray’s down in the dumps. Although three times its IPO price, Tilray stock has lost 68% of its value since September,…
Author: admin
4 Marijuana Stocks With Superior Crop Yields
The past six months have been an absolute whirlwind for the marijuana industry. In October, we witnessed the industry gain the legitimacy it’s sought for so long after Canada became the first industrialized country in the world to legalize recreational…
3 Marijuana Stocks to Consider Buying in March
To be blunt, marijuana stocks are on fire. Following the passage of the Cannabis Act in Canada this past June, and the official kickoff of recreational weed sales on Oct. 17, 2018, the cannabis industry is now viewed as a…
3 Marijuana Stocks to Avoid Like the Plague in March
Following a blazing hot January, marijuana stocks cooled a bit in February but still advanced for the month. Through the first two months of 2019, the Horizons Marijuana Life Sciences ETF, which holds around four dozen pot stocks at various…
1 Hot Marijuana Stock to Buy in March
If you’re on the hunt for a great marijuana stock to buy, remember that sometimes taking the road less traveled is the best choice. Big Canadian marijuana producers get the most attention. That makes sense in some ways because of…
2 Pot Stocks Expected to Fall at Least 25%
The marijuana industry is growing at a blistering pace, and it’s led to rapid appreciation in most marijuana stocks. With the exception of the fourth quarter, pot stocks have been mostly unstoppable since the beginning of 2016. In January alone,…
Better Marijuana Buy: Canopy Growth vs. Constellation Brands
Marijuana stocks have soared in 2019, and many mainstream investors are looking at taking their first steps into the cannabis investing arena. It’s not surprising, though, that many new investors in cannabis are reluctant to make big bets on the…
Is GW Pharmaceuticals (GWPH) a buy after reporting quarterly results?
GW Pharmaceuticals (NASDAQ:GWPH) has the distinction of being the only company to secure Food and Drug Administration (FDA) approval for a cannabidiol (CBD) marijuana therapy. The company’s Epidiolex won the FDA green light last summer after demonstrating it reduces seizures…
3 Under-the-Radar Cannabis Stocks to Buy
Just as investors who follow the stock market have heard of Apple (NASDAQ:AAPL), Amazon (NASDAQ:AMZN), and Microsoft(NASDAQ:MSFT), investors who follow the cannabis industry have heard of that industry’s giants of marijuana stocks, like Canopy Growth (NYSE:CGC), Aurora Cannabis (NYSE:ACB), and Tilray (NASDAQ:TLRY). And just like there are strong opportunities aside from the…
What’s Trump Really Going to Do About Marijuana?
In 2015, when running for president, Donald Trump was asked about Colorado’s legalization of recreational marijuana. “I think it’s bad,” he said at the time, “and I feel strongly about it.” However, he later modified his stance on marijuana, stating…